Rivaroxaban tablets have several indications, including reducing the risk of stroke and systemic embolism in nonvalvular ...

Mumbai: Global pharma major Lupin Limited has received approval from the United States Food and Drug Administration (U.S. FDA ...

Lupin receives US FDA approval for rivaroxaban tablets USP, 10 mg, 15 mg & 20 mg: Our Bureau, Mumbai Thursday, May 15, 2025, 15:40 Hrs [IST] Global pharma major Lupin Limited (Lup ...

Rivaroxaban, an oral anticoagulant, helps prevent the formation of blood clots by inhibiting Factor Xa, an essential protein ...

Drugmaker Lupin has received U.S. Food and Drug Administration (U.S. FDA) approval for Rivaroxaban Tablets USP, 10 mg, 15 mg, and 20 mg, its generic version of Janssen Pharmaceuticals’ blood thinner ...

Lupin announced that it has received approval from the United States Food and Drug Administration (U.S. FDA) for its Abbreviated New Drug Application for Rivaroxaban Tablets USP, 10 mg, 15 mg, and 20 ...